BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 33094910)

  • 1. Incidence and survival for oropharynx and non-oropharynx head and neck cancers among veterans living with HIV.
    Mazul AL; Hartman C; Kramer J; White DL; Royse K; Raychaudhury S; Sandulache V; Ahmed ST; Richardson P; Sikora AG; Chiao E
    Cancer Med; 2020 Dec; 9(24):9326-9335. PubMed ID: 33094910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk and incidence of head and neck cancers in veterans living with HIV and matched HIV-negative veterans.
    Mazul AL; Hartman CM; Mowery YM; Kramer JR; White DL; Royse KE; Raychaudhury S; Sandulache VC; Ahmed ST; Zevallos JP; Richardson PA; Sikora AG; Chiao EY
    Cancer; 2022 Sep; 128(18):3310-3318. PubMed ID: 35867552
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synchronous cancers in patients with head and neck cancer: risks in the era of human papillomavirus-associated oropharyngeal cancer.
    Jain KS; Sikora AG; Baxi SS; Morris LG
    Cancer; 2013 May; 119(10):1832-7. PubMed ID: 23423883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characteristics of Human Papillomavirus-Associated Head and Neck Cancers in a Veteran Population.
    Shay SG; Chang E; Lewis MS; Wang MB
    JAMA Otolaryngol Head Neck Surg; 2015 Sep; 141(9):790-6. PubMed ID: 26270931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence and risk factors of HPV-related and HPV-unrelated Head and Neck Squamous Cell Carcinoma in HIV-infected individuals.
    Beachler DC; Abraham AG; Silverberg MJ; Jing Y; Fakhry C; Gill MJ; Dubrow R; Kitahata MM; Klein MB; Burchell AN; Korthuis PT; Moore RD; D'Souza G;
    Oral Oncol; 2014 Dec; 50(12):1169-76. PubMed ID: 25301563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors for oropharynx cancer in a cohort of HIV-infected veterans.
    Chew EY; Hartman CM; Richardson PA; Zevallos JP; Sikora AG; Kramer JR; Chiao EY
    Oral Oncol; 2017 May; 68():60-66. PubMed ID: 28438295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence and Demographic Burden of HPV-Associated Oropharyngeal Head and Neck Cancers in the United States.
    Mahal BA; Catalano PJ; Haddad RI; Hanna GJ; Kass JI; Schoenfeld JD; Tishler RB; Margalit DN
    Cancer Epidemiol Biomarkers Prev; 2019 Oct; 28(10):1660-1667. PubMed ID: 31358520
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluating human papillomavirus testing, prevalence, and association with prognosis in head and neck squamous cell carcinoma by subsite: A national cancer database study.
    Barlow J; Gilja S; Ferrandino RM; Berger MH; Posner MR; Bakst RL; Khan MN; Teng MS; Genden EM; Chai RL; Roof SA
    Am J Otolaryngol; 2024; 45(3):104243. PubMed ID: 38442460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and Assessment of a Novel Composite Pathologic Risk Stratification for Surgically Resected Human Papillomavirus-Associated Oropharyngeal Cancer.
    Cramer JD; Dundar Y; Hotaling J; Raza SN; Lin HS
    JAMA Otolaryngol Head Neck Surg; 2019 Dec; 145(12):1105-1114. PubMed ID: 31042786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Second primary cancers after an index head and neck cancer: subsite-specific trends in the era of human papillomavirus-associated oropharyngeal cancer.
    Morris LG; Sikora AG; Patel SG; Hayes RB; Ganly I
    J Clin Oncol; 2011 Feb; 29(6):739-46. PubMed ID: 21189382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disparate survival of late-stage male oropharyngeal cancer in Appalachia.
    Papenberg BW; Allen JL; Markwell SM; Interval ET; Montague PA; Johnson CJ; Weed SA
    Sci Rep; 2020 Jul; 10(1):11612. PubMed ID: 32669588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence and Risk of Second Primary Malignant Neoplasm After a First Head and Neck Squamous Cell Carcinoma.
    Adjei Boakye E; Buchanan P; Hinyard L; Osazuwa-Peters N; Schootman M; Piccirillo JF
    JAMA Otolaryngol Head Neck Surg; 2018 Aug; 144(8):727-737. PubMed ID: 30027284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of human papillomavirus-associated cancers among persons with AIDS.
    Chaturvedi AK; Madeleine MM; Biggar RJ; Engels EA
    J Natl Cancer Inst; 2009 Aug; 101(16):1120-30. PubMed ID: 19648510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The epidemiology of head and neck squamous cell carcinoma in The Netherlands during the era of HPV-related oropharyngeal squamous cell carcinoma. Is there really evidence for a change?
    van Monsjou HS; Schaapveld M; van den Brekel MW; Balm AJ
    Oral Oncol; 2015 Oct; 51(10):901-7. PubMed ID: 26216340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Head and neck second primary cancer rates in the human papillomavirus era: A population-based analysis.
    Diaz DA; Reis IM; Weed DT; Elsayyad N; Samuels M; Abramowitz MC
    Head Neck; 2016 Apr; 38 Suppl 1():E873-83. PubMed ID: 25966421
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The changing incidence of human papillomavirus-associated oropharyngeal cancer using multiple imputation from 2000 to 2010 at a Comprehensive Cancer Centre.
    Habbous S; Chu KP; Qiu X; La Delfa A; Harland LT; Fadhel E; Hui A; Perez-Ordonez B; Weinreb I; Liu FF; Waldron J; O'Sullivan B; Goldstein D; Xu W; Huang SH; Liu G
    Cancer Epidemiol; 2013 Dec; 37(6):820-9. PubMed ID: 24184275
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HPV-Positive Oropharyngeal Cancer Via p16 Immunohistochemistry in Japan.
    Toman J; Von Larson S; Umeno H; Kurita T; Furusaka T; Hasegawa H; Prasad ML; Sasaki CT
    Ann Otol Rhinol Laryngol; 2017 Feb; 126(2):152-158. PubMed ID: 27913709
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence trends in head and neck cancers and human papillomavirus (HPV)-associated oropharyngeal cancer in Canada, 1992-2009.
    Forte T; Niu J; Lockwood GA; Bryant HE
    Cancer Causes Control; 2012 Aug; 23(8):1343-8. PubMed ID: 22718355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HPV Status Improves Classification of Head and Neck Gray Zone Cancers.
    Ren J; Xu W; Su J; Ren X; Bender N; Habbous S; de Almeida JR; Goldstein DP; Cheng D; Chen Z; Mirshams M; Rahini M; Huang SH; Spreafico A; Hansen A; Kim J; Waldron J; Perez-Ordonez B; Zhao Y; Hung R; Waterboer T; Liu G
    J Dent Res; 2019 Jul; 98(8):879-887. PubMed ID: 31282843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HPV DNA in saliva from patients with SCC of the head and neck is specific for p16-positive oropharyngeal tumours.
    Wasserman JK; Rourke R; Purgina B; Caulley L; Dimitroulakos J; Corsten M; Johnson-Obaseki S
    J Otolaryngol Head Neck Surg; 2017 Jan; 46(1):3. PubMed ID: 28061890
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.